DeepTech

DeepTech is the catch-all term for venture-backed companies built on unproven scientific and engineering advances - quantum computing, nuclear fusion, advanced materials, synthetic biology, neuromorphic computing, photonics - rather than on application-layer software. The defining characteristic is long capital cycles (often 10-20 years from founding to revenue), high technical risk, and a heavy reliance on government and strategic capital alongside venture funding. The DeepTech category absorbed an estimated $80B globally in 2024 across all sub-themes per Dealroom data, and remains one of the few areas where US, EU and Chinese state programmes are explicitly funding private companies at scale.

The sector spans quantum computing, nuclear fusion, synthetic biology, advanced materials and metamaterials, neuromorphic and photonic computing, and brain-computer interfaces.

Revenue comes from government and defence research contracts, hardware-as-a-service subscriptions (quantum cloud access), one-off pilot deployments to industrial and pharma customers, IP licensing, and milestone-based partnership revenue with strategic corporate partners.

DeepTech is part of Industrial technology.

$154B

Global market size

1463

Public companies

Y Combinator
Techstars
Alumni Ventures
Khosla Ventures

Key VC investors

Qualcomm
Amazon
Cadence Design Systems
Quantum Systems

Key strategic buyers

Business model

How DeepTech companies monetize?

Deeptech companies monetize through government research contracts, quantum-as-a-service subscriptions and strategic partnership milestones.

Government research contracts

DoE, DARPA, ARPA-E, ARIA UK, EU Horizon and Chinese government funding for long-cycle research. The dominant revenue line for fusion, quantum and advanced materials companies pre-commercial.

Quantum-as-a-service

Cloud access subscriptions to quantum computers via AWS Braket, Azure Quantum and IBM Q. IBM, Quantinuum and IonQ all report this revenue line.

Pilot deployments

One-off engineering contracts with pharma, financial services and energy customers exploring DeepTech use cases. Revenue lumpy and customer-specific.

IP licensing

Royalties on patented chemistries, materials or algorithms used by larger industrial partners. Standard for advanced-materials and biotech-adjacent DeepTech.

Strategic partnership revenue

Milestone payments and co-development revenue from corporate partners (Boeing, Pfizer, JP Morgan, Mitsubishi). Validates the technology and funds R&D.

Equipment sales

One-off sales of bench-scale hardware (cryostats, photonic chips, fusion components) to research labs and other DeepTech companies. Small but recurring.

DeepTech valuations in May 2026

Public DeepTech comps trade at 4.2x EV/Revenue. Median revenue multiple across DeepTech M&A deals was 2.9x in the last 12 months. Median revenue multiple across DeepTech VC rounds was 19x in the last 12 months.

4.2x

Median EV/Revenue as of May 2026 for public DeepTech companies

24x

NVIDIA

NVIDIA is the highest valued public DeepTech company based on EV/Revenue (excluding outliers)

2.9x

Median EV/Revenue across DeepTech M&A deals in the last 12 months

19x

Median EV/Revenue across DeepTech VC rounds in the last 12 months

Sector breakdown

DeepTech market segments

Deeptech spans quantum computing, nuclear fusion and brain-computer interfaces.

Quantum computing hardware

Companies building gate-model and analog quantum computers, including superconducting, trapped-ion, photonic and neutral-atom architectures. IBM, Google Quantum AI, IonQ (NYSE: IONQ), Rigetti (NASDAQ: RGTI), PsiQuantum, Atom Computing and Quantinuum lead.

Nuclear fusion

Private fusion energy companies pursuing tokamak, stellarator, magnetised target and inertial confinement paths. Commonwealth Fusion Systems (raised $1.8B Series B in 2021), Helion (raised $425M in 2024 with $1.7B more committed pending milestones), TAE Technologies, Tokamak Energy and Zap Energy are the reference names.

Synthetic biology platforms

Engineered microbes and platforms for industrial-scale fermentation, novel materials and protein production. Ginkgo Bioworks (NYSE: DNA, traded down 95%+ from SPAC peak), Zymergen (acquired by Ginkgo in 2022), Twist Bioscience and Asimov sit here.

Advanced materials & metamaterials

Engineered materials for batteries, sensors, optics and structural applications. Sila Nano (raised $375M Series H in 2024), Group14 Technologies (silicon battery), Lyten and Metalenz lead.

Neuromorphic & photonic computing

Non-von Neumann compute architectures for AI inference and high-performance computing. Lightmatter, Ayar Labs, Celestial AI (raised $175M Series C in 2025), Rain AI and BrainChip lead.

Brain-computer interfaces

Implanted and non-invasive BCI hardware for medical and consumer applications. Neuralink (private, valued $5B in 2023; first human implant 2024), Synchron, Paradromics and Precision Neuroscience are the reference names.

Fractional CFO, financial modelling and deal advice for DeepTech companies

See how Flow helps DeepTech founders.

We speak founders' language and have great operational understanding of DeepTech businesses.

Book an intro call - we'll look under the hood and recommend concrete next steps.

Explore pricing
Sector KPIs

Key DeepTech KPIs to track

Capital raised, cash runway, technical milestone progress and government contract backlog are the metrics investors track in deeptech.

KPIDefinition
Capital raisedCumulative equity and debt funding since inception. The first metric for any DeepTech company because revenue is typically immaterial pre-commercial.
Cash runwayMonths of operating cash at current burn rate. The most-watched metric because most DeepTech companies are years from positive cash flow.
Revenue growthYear-on-year revenue change. Standard once a company has crossed into commercial deployment.
Government contract backlogSigned but undelivered government and DoD research contracts. The cleanest revenue forward-indicator for DeepTech pre-commercial.
Technical milestone progressIndependently verified progress against scientific milestones (qubit fidelity, fusion energy gain, materials yield). The proxy investors use in absence of revenue.
Patents filed / grantedIP portfolio size and trajectory. Critical for materials and biotech-adjacent DeepTech where royalty business models depend on it.
Strategic partnership countActive corporate partnerships with credible industrial or scientific partners. The signal of commercial pull-through ahead of revenue.
Talent densityPhD or equivalent share of headcount. The leading indicator of execution capability in DeepTech and tracked by sophisticated investors during diligence.
Key players

Main DeepTech players globally

The most active deeptech companies and category leaders globally.

CompanyHQOverview
IBM Quantum
ibm.com
Armonk
Largest cumulative investor in quantum computing among public companies; shipped the 1,121-qubit Condor processor in 2023 and the 156-qubit Heron in 2024. Quantum-as-a-service via IBM Quantum Network.
College Park
Listed on NYSE as IONQ. First pure-play quantum hardware company to go public (via SPAC in 2021). Trapped-ion architecture; signed multi-year contracts with US Air Force and DARPA in 2024-25.
PsiQuantum
psiquantum.com
Palo Alto
Photonic quantum computing company; signed AUD 940M deal with Australian and Queensland governments to build a utility-scale machine in Brisbane (announced 2024). Last private valuation around $3B.
Atom Computing
atom-computing.com
Berkeley
Neutral-atom quantum computing developer. Demonstrated a 1,180-qubit machine in 2023 with Microsoft; raised $60M Series B in 2022.
Commonwealth Fusion Systems
cfs.energy
Devens
Tokamak-based fusion company spun out of MIT. Raised $1.8B Series B in 2021 led by Tiger Global and Bill Gates; SPARC commissioning targeted for 2027 with first net energy gain. Largest private fusion company by funding.
Helion Energy
helionenergy.com
Everett
Pulsed magnetic-confinement fusion company. Sam Altman is the largest investor. Signed a 50MW power purchase agreement with Microsoft in 2023 for delivery by 2028. Raised $425M Series F in 2024 with $1.7B additional commitments tied to milestones.
TAE Technologies
tae.com
Foothill Ranch
Field-reversed-configuration fusion company. Has raised over $1.2B to date. Diversified into power management and proton-boron fusion research.
Ginkgo Bioworks
ginkgobioworks.com
Boston
Listed on NYSE as DNA. Synthetic biology foundry; stock traded down over 95% from SPAC peak. Restructured in 2024 with significant headcount reductions to extend runway.
Sila Nano
silanano.com
Alameda
Silicon-anode battery materials. Mercedes-Benz EQG is the anchor automotive customer. Raised $375M in 2024 to scale its Moses Lake, WA facility.
Neuralink
neuralink.com
Fremont
Elon Musk's brain-computer interface company. First human Telepathy implant in January 2024; second and third patients implanted through 2024-25. Last valued at $5B in 2023.

CFO-as-a-service, on your terms.

Fractional CFO services scoped to your stage - a few days a month or embedded through a raise.

Market trends

Key DeepTech market trends

Quantum logical-qubit breakthroughs, the fusion private capital wave and photonic-AI acceleration are reshaping deeptech right now.

Quantum logical-qubit breakthroughs

Google demonstrated a fault-tolerant logical qubit on Willow in December 2024; Microsoft and Atom Computing demonstrated 28 entangled logical qubits in late 2024; IBM published a refined roadmap targeting 200 logical qubits by 2029. The narrative has shifted from physical qubit counts to fault-tolerance milestones. Dated December 2024.

Fusion private capital wave

Helion raised $425M Series F in early 2024; Pacific Fusion raised $900M in October 2024 from General Catalyst, Lightspeed and Lowercarbon; Realta Fusion raised $36M Series A in 2024; the Fusion Industry Association now tracks over 40 private fusion companies with cumulative private capital above $7B. Dated October 2024.

Photonic-AI acceleration

Lightmatter raised $400M Series D at $4.4B valuation in late 2024; Celestial AI raised $175M Series C in 2025 led by Fidelity at over $2.5B; Ayar Labs raised $155M Series D in late 2024. NVIDIA's photonic switch roadmap and Broadcom's CPO platform validate the category for hyperscale AI workloads. Dated March 2025.

US CHIPS Act and Microelectronics Commons

The US National Semiconductor Technology Center (NSTC) and the $2B Microelectronics Commons program funded eight regional hubs in 2024-25. The Center for Quantum Engineering, NEXUS for advanced packaging and other consortia are pulling DeepTech R&D into a US-government-coordinated framework. Dated February 2025.

PsiQuantum-Australia utility-scale deal

PsiQuantum signed a roughly AUD 940M (around USD 620M) deal with the Australian federal and Queensland state governments in April 2024 to build a utility-scale photonic quantum computer in Brisbane. Largest single sovereign commitment to a private quantum company. Dated April 2024.

Ginkgo and synbio reset

Ginkgo Bioworks restructured in 2024 with around 35% workforce reductions and pulled its near-term revenue guidance, marking a broader synbio reset. Zymergen folded into Ginkgo in 2022 after its $3B SPAC peak collapsed. The synbio platform thesis is being rebuilt around narrower applications. Dated August 2024.

Similar verticals to DeepTech

Explore niches like 3D printing, automation & robotics, test & measurement and sensors & monitoring.

Explore other sectors

We know tech inside & out.

We live and breath tech - true understanding of how startups operate is fundamental at what we do.

SoftwareAI & MLFintechConsumer internetDigital mediaE-commerce & marketplacesConsumer productsMobilityDigital healthIndustrial technologyDigital infrastructureIT services

Recent insights across DeepTech and beyond

Talk to us

Schedule a call to get a health check on your business and see how we could help.

Fractional CFO

Stages

Countries

Cities

Sectors

© 2026 Flow Partners (London) Ltd. All rights reserved. Registered as a limited liability company in England and Wales (registered number 12969521).